EU regulator approves injectable HIV drug that experts say could help stop transmission
In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is 'highly effective' and 'considered to be of major public health interest.' Once the regulator's guidance is accepted by the European Commission, the authorization is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein.
Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping transmission in both women and men.
Winnie Byanyima, executive director of the U.N. AIDS agency, has said the drug 'could change the trajectory of the HIV epidemic' if it is made available to everyone who needs it.
In June, the U.S. Food and Drug Administration authorized lenacapavir to prevent HIV. Earlier this month, the World Health Organization recommended countries offer the drug as an additional option to people at risk of the virus.
Condoms help guard against HIV infection if used properly. Other medication aimed at preventing HIV include daily pills that people can take and another injectable drug called cabotegravir, which is given every two months. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more visits to health clinics or stigma from taking daily pills.
Critics have raised concerns, however, that lenacapavir may not be made widely enough available to stop global outbreaks of HIV. Drugmaker Gilead has said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates — mostly in Africa, Southeast Asia and the Caribbean.
But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease.
Last year, there were about 630,000 AIDS deaths worldwide and more than 40 million people are estimated to have HIV, according to UNAIDS.
UNAIDS chief Byanyima has previously suggested the U.S. President Donald Trump make a deal with Gilead to produce and license its 'magical' prevention drug lenacapavir across the world to the millions of people who need it.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
6 hours ago
- CBC
A new Toronto HIV clinic is 'bridging the gap' in care with free medication and more
A new, free-of-charge clinic in downtown Toronto is hoping to change lives for people living with human immunodeficiency virus (HIV). For people without coverage, it can be next to impossible to afford the medication needed to manage HIV. But access to medication isn't the only service that the Toronto People With AIDS Foundation (PWA) offers. The PWA says it provides immigration services, a food bank and a lunch program to people in Toronto living with HIV. Ower Oberto, the linkage to care manager at the centre, lives with HIV and came to Canada in 2014. "I know how stressful it is not having access to medication," he said. When he first immigrated from Venezuela, Oberto says he didn't know how or even if he could source his medication as a newcomer. "People living with HIV with precarious immigration status, they wouldn't be able to see a doctor or they have to pay that doctor with money out of pocket," he said. "My medication costs more than $1,200 per month." Eleven years later, he now works at the PWA's new clinic providing medication to people with HIV. The clinic was created in partnership with Freddie — a health organization that specializes in HIV prevention and care. "For us it's been an amazing partnership," Oberto said. "We feel like we are family." The PWA's one-room clinic is staffed with two nurses and sees patients once a week, on Wednesdays. Clients don't need to be covered by OHIP or insurance, and vary in immigration status, from international students, to visitors and citizens. "We are bridging all the gaps that have been [letting] … those folks fall into the cracks," Oberto said. "The population we see is a population that is also not easy to support because they don't fill the criteria for the other clinics that are in the city." Clients are set up with patient assistance programs offered by pharmaceutical companies and leave the clinic medication in hand. The clinic is located on the third floor of the PWA's building near Jarvis Street and Queen Street E. Currently the clinic is running a pilot, which began in June. But Oberto has big dreams of scaling up so that it can serve more people with extended hours. "We are looking forward to [having] more days or more hours, because it's getting busier," he said. "We are looking forward … to [having] a bigger clinic and also to have a pharmacy here downstairs." Though the HIV-positive population in Canada is relatively small — approximately 62,790 as of 2020, according to a 2022 Public Health Agency of Canada (PHAC) report. That number is now growing despite education and prevention campaigns. According to PHAC, 2,434 people learned they carried the virus in 2023, up 35 per cent from the previous year. Of those diagnosed across Canada, PHAC estimates 87 per cent are in treatment and 95 per cent of those have suppressed viral loads, which doctors say makes the virus undetectable, untransmittable and prevents it from progressing to AIDS. A decade ago, the United Nations set a goal to eradicate the HIV epidemic by 2030. "This is the best way to do it," Oberto said.
Winnipeg Free Press
13 hours ago
- Winnipeg Free Press
For some Zimbabwe children with heart disease, a rare lifeline restores hope
HARARE, Zimbabwe (AP) — Tubes snaked across 3-year-old Gracious Chikova's bandaged chest in the intensive care unit of a government hospital in Zimbabwe's capital, Harare. Just a day earlier, surgeons had opened her tiny heart to repair a defect that threatened her life. Now she sipped a drink from a syringe, her mother anxiously watching her every breath. 'I had given up. Those with money have been taking their children to India for surgery, but I simply couldn't afford it,' said Vimbainashe Chakanungwa as she helped her daughter sip her meal. Chakanungwa's monthly salary as a teacher is about $300, barely enough for household basics, let alone surgery. Gracious is one of 10 children who received free open-heart surgery in July at Parirenyatwa Hospital from a visiting team of Egyptian surgeons working alongside Zimbabwean doctors. In a country with just a handful of cardiothoracic specialists and chronic shortages of functioning equipment in public hospitals, the 'heart camp' offered hope to families who can't imagine raising the $15,000 needed for surgery abroad. Zimbabwe has only five cardiothoracic surgeons, including Dr. Kudzai Kanyepi, the country's first and only female heart surgeon. 'There is no medication that can replace surgery. The burden of disease remains, and unfortunately some of the children pass away without getting the help they desperately need,' Kanyepi said. 'It is the reason why we continue to work in our country. There is nothing greater than helping your own people.' Zimbabwe resumed open-heart operations in 2023 after they were paused in 2018 due to economic turmoil. Since then, local surgeons have operated on 55 children. Another 19 have benefited from two surgical camps last year and in July with Egyptian assistance and supported by nongovernmental organizations such as Gift of Life International. Globally, about one in every 100 children is born with congenital heart disease, making it the world's most common birth defect, according to the U.S. Centers for Disease Control and Prevention. In Zimbabwe, an estimated 4,500 children are born with heart disease each year, with many unable to access surgery, said Dr. Simukayi Machawira, head of cardiology at the hospital. Of those, 30% — or around 1,200 infants — are likely to die in their first year if untreated, he said. 'You can imagine, it's quite a lot of children,' he said. Dr. Hesham Shawky, the Egyptian team leader, has organized similar camps in Kenya and Uganda. 'This is the only solution for many people in Africa because they can't afford private care,' he said. On the ward in Zimbabwe, mothers hovered over their children, relief etched on their faces. Machines beeped softly as nurses adjusted tubes. One baby slept beside a balloon scrawled with a smiley face. For Chakanungwa, the joy over her child was hard to measure. 'I had resorted to prayer, just hoping for a miracle,' Chakanungwa said, smiling. 'It's impossible to open my heart to show my gratitude and happiness. I was afraid that I could lose my baby, but here is the baby. She's back to life.' ___ For more on Africa and development: The Associated Press receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at
CBC
16 hours ago
- CBC
How this Toronto clinic is aiming to help people living with HIV
A new clinic in Toronto is aiming to provide free, accessible medication and care to those living with HIV. CBC's Ali Chiasson visited the facility to learn more about their supports.
